These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hope fear and genetics: judicial responses to biotechnology. Gold ER Judicature; 1999; 83(3):132-8. PubMed ID: 12737164 [No Abstract] [Full Text] [Related]
4. [Predisposition to breast cancer: Europe closes its doors to Myriad Genetics (Salt Lake City)]. Nau JY Rev Med Suisse; 2007 Oct; 3(128):2320. PubMed ID: 17985613 [No Abstract] [Full Text] [Related]
5. Assessing controversial direct-to-consumer advertising for hereditary breast cancer testing: reactions from women and their physicians in a managed care organization. Mouchawar J; Laurion S; Ritzwoller DP; Ellis J; Kulchak-Rahm A; Hensley-Alford S Am J Manag Care; 2005 Oct; 11(10):601-8. PubMed ID: 16232001 [TBL] [Abstract][Full Text] [Related]
6. Genetic testing for breast and ovarian cancer susceptibility: a family experience. Van Riper M; McKinnon WC J Midwifery Womens Health; 2004; 49(3):210-9. PubMed ID: 15134674 [TBL] [Abstract][Full Text] [Related]
7. Polygenes, risk prediction, and targeted prevention of breast cancer. Wilkins RJ N Engl J Med; 2008 Sep; 359(13):1406. PubMed ID: 18815404 [No Abstract] [Full Text] [Related]
8. Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2004 Jul; 53(27):603-6. PubMed ID: 15254451 [TBL] [Abstract][Full Text] [Related]
9. Hereditary breast and ovarian cancer syndrome: should we test adolescents? Seeber B; Driscoll DA J Pediatr Adolesc Gynecol; 2004 Jun; 17(3):161-7. PubMed ID: 15125901 [No Abstract] [Full Text] [Related]
10. "Be ready against cancer, now": direct-to-consumer advertising for genetic testing. William-Jones B New Genet Soc; 2006 Apr; 25(1):89-107. PubMed ID: 17312631 [TBL] [Abstract][Full Text] [Related]
11. Direct-to-patient BRCA1 testing: the Twoj Styl experience. Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; LubiĆski J Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675 [TBL] [Abstract][Full Text] [Related]
12. Europe to pay royalties for cancer gene. Abbott A Nature; 2008 Dec; 456(7222):556. PubMed ID: 19052591 [No Abstract] [Full Text] [Related]
13. Patient education. Family history of breast cancer. NSW Breast Cancer Institute Aust Fam Physician; 2006; 35(1-2):49-50. PubMed ID: 16502546 [No Abstract] [Full Text] [Related]
14. Breast cancer research neglects non-Jewish groups, experts charge. Keim B Nat Med; 2006 Dec; 12(12):1335. PubMed ID: 17151676 [No Abstract] [Full Text] [Related]
15. Genetic susceptibility to breast and ovarian cancer: risk assessment, genetic counseling, and management issues. Shah MR Mo Med; 2004; 101(2):105-10; quiz 110-1. PubMed ID: 15119107 [TBL] [Abstract][Full Text] [Related]
16. Genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations. Silva E; Lynch H Breast J; 2006; 12(3):280-1; author reply 282-4. PubMed ID: 16684334 [No Abstract] [Full Text] [Related]
17. Array of possibilities opens up in genotyping. Gewin V Nature; 2005 Jun; 435(7046):1159. PubMed ID: 15988493 [No Abstract] [Full Text] [Related]
19. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome. Ross JS Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609 [TBL] [Abstract][Full Text] [Related]
20. A literature review of the psychological impact of genetic testing on breast cancer patients. Schlich-Bakker KJ; ten Kroode HF; Ausems MG Patient Educ Couns; 2006 Jul; 62(1):13-20. PubMed ID: 16242293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]